Osteoarthritis Therapy: Nanocrystal-Polymer Particles: Extended Delivery Carriers for Osteoarthritis Treatment (Small 8/2018)

Cell Therapy for Osteoarthritis

Osteoarthritis (OA) also known as degenerative joint disease or degenerative arthritis is the most common chronic condition of the joints. It mainly damages the articular cartilage which results in pain, swelling and stiffness around the joints. It is the leading cause of disability and pain. Current therapeutic strategies are expensive and they are capable of eradicating only the symptoms of O...

Gene Therapy for Human Osteoarthritis

Controversy: hirudotherapy (leech therapy) as an alternative treatment for osteoarthritis.

Osteoarthritis (OA) is the most common degenerative joint disease found in the elderly. Drug options that are recommended by the American Academy of Orthopaedic Surgeon (AAOS) are acetaminophen, NSAIDs, tramadol, capscaicin and intraarticular corticosteroids. However, there is concern for the possible side effects resulting from long term use of those medications. Researchers are searching for ...

Moxibustion Treatment for Knee Osteoarthritis

To determine whether the administration of moxibustion is an effective treatment for knee osteoarthritis (KOA).We conducted a search of relevant articles using Medline, EMBASE, the Web of Science, and the Cochrane Library published before October 2015. The Western Ontario and McMaster Universities' Osteoarthritis Index (WOMAC scale) and the short form 36 questionnaire (SF-36 scale) were assesse...

Osteoarthritis and therapy.

Introduction Osteoarthritis (OA) is the leading cause of disability in older persons, affecting 10% of the population 60 years of age. In the United States alone, there are currently at least 20 million persons afflicted with OA, which costs the economy approximately $60 billion annually. Eighty percent of individuals with OA have limited mobility and 25% cannot perform major daily activities (...